Literature DB >> 7595678

Electrophysiological studies in Guillain-Barré syndrome: correlation with antibodies to GM1, GD1B and Campylobacter jejuni.

F J Vriesendorp1, W J Triggs, R F Mayer, C L Koski.   

Abstract

A retrospective study of 50 patients with Guillain-Barré syndrome (GBS) correlated analysis of serial motor nerve conduction studies with the presence of antibodies to Campylobacter jejuni, GM1 and GD1b, determined by ELISA. GBS patients with antibodies to C. jejuni (n = 8), GM1 (n = 4), or GD1b (n = 4) showed electrophysiological features suggestive of demyelination with prolonged distal motor latencies and temporal dispersion/conduction block similar to GBS patients without these specific antibodies. Three of 50 GBS patients had poor recovery with inability to walk at 1 year after onset of symptoms. All three patients had antibodies to C. jejuni, but not to GM1 or GD1b. Although later on in the clinical course distal motor responses were absent in two of these patients, reflecting extensive axonal degeneration, early nerve conduction studies showed findings suggestive of demyelination. We suggest that demyelination of peripheral nerve may be the initial disease mechanism in GBS independent of the presence of antibodies to C. jejuni, GM1 or GD1b.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595678     DOI: 10.1007/BF00873550

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  29 in total

1.  Pseudoaxonal Guillain-Barré syndrome: severe demyelination mimicking axonopathy. A case with pupillary involvement.

Authors:  G N Fuller; J M Jacobs; P D Lewis; R J Lane
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

Review 2.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

3.  Guillain-Barré syndrome and Campylobacter jejuni: a serological study.

Authors:  J Kaldor; B R Speed
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-23

4.  Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome.

Authors:  M K Sharief; B McLean; E J Thompson
Journal:  Ann Neurol       Date:  1993-06       Impact factor: 10.422

5.  An acute axonal form of Guillain-Barré polyneuropathy.

Authors:  T E Feasby; J J Gilbert; W F Brown; C F Bolton; A F Hahn; W F Koopman; D W Zochodne
Journal:  Brain       Date:  1986-12       Impact factor: 13.501

6.  Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.

Authors:  F J Vriesendorp; B Mishu; M J Blaser; C L Koski
Journal:  Ann Neurol       Date:  1993-08       Impact factor: 10.422

7.  Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation.

Authors:  C L Koski; R Humphrey; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

8.  Motor nerve inexcitability in Guillain-Barré syndrome. The spectrum of distal conduction block and axonal degeneration.

Authors:  W J Triggs; D Cros; S C Gominak; G Zuniga; A Beric; B T Shahani; A H Ropper; S M Roongta
Journal:  Brain       Date:  1992-10       Impact factor: 13.501

9.  Electrophysiologic studies in the Guillain-Barré syndrome: effects of plasma exchange and antibody rebound.

Authors:  S Rudnicki; F Vriesendorp; C L Koski; R F Mayer
Journal:  Muscle Nerve       Date:  1992-01       Impact factor: 3.217

10.  Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.

Authors:  N Yuki; M Yamada; S Sato; E Ohama; Y Kawase; F Ikuta; T Miyatake
Journal:  Muscle Nerve       Date:  1993-06       Impact factor: 3.217

View more
  4 in total

Review 1.  Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants.

Authors:  J W Terryberry; Y Shoenfeld; J B Peter
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  Ganglioside agglutination immunoassay for rapid detection of autoantibodies in immune-mediated neuropathy.

Authors:  A Alaedini; I Wirguin; N Latov
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

3.  Passive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair.

Authors:  Pablo H Lopez; Gang Zhang; Jiangyang Zhang; Helmar C Lehmann; John W Griffin; Ronald L Schnaar; Kazim A Sheikh
Journal:  J Neurosci       Date:  2010-07-14       Impact factor: 6.167

Review 4.  Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.

Authors:  Kenichi Kaida; Toshio Ariga; Robert K Yu
Journal:  Glycobiology       Date:  2009-02-24       Impact factor: 4.313

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.